Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-15 Sale | 2023-09-18 4:44 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 10,500 | $8.16 | $85,680 | 94,360 (Direct) | View |
| 2023-07-06 Sale | 2023-07-10 4:42 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,500 | $10.8 | $59,400 | 59,860 (Direct) | View |
| 2023-06-30 Sale | 2023-07-05 4:32 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $11.41 | $57,050 | 110,360 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 5:04 pm | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 7,437 | $7.83 | $58,232 | 214,618 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 5:02 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 1,259 | $7.83 | $9,858 | 71,617 (Direct) | View |
| 2023-03-20 Sale | 2023-03-22 4:49 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 2,193 | $7.76 | $17,018 | 65,360 (Direct) | View |
| 2023-03-20 Sale | 2023-03-22 4:48 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 3,654 | $7.76 | $28,355 | 72,876 (Direct) | View |
| 2023-03-20 Sale | 2023-03-22 4:47 pm | Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel | 4,410 | $7.76 | $34,222 | 102,200 (Direct) | View |
| 2023-03-15 Sale | 2023-03-17 4:37 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 15,373 | $8.2 | $126,059 | 76,530 (Direct) | View |
| 2023-02-23 Purchase | 2023-02-24 06:15 am | Voyager Therapeutics Inc. | VYGR | NEUROCRINE BIOSCIENCES INC 10% Owner | 4,395,588 | $8.88 | $39,032,821 | 8,575,316 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 8:58 pm | Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel | 3,297 | $7.45 | $24,563 | 106,610 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 8:57 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 738 | $7.45 | $5,498 | 135,553 (Direct) | View |
| 2023-02-13 Sale | 2023-02-15 4:53 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 797 | $7.67 | $6,113 | 34,291 (Direct) | View |
| 2023-02-13 Sale | 2023-02-15 4:52 pm | Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel | 2,868 | $7.67 | $21,998 | 109,907 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 7:26 pm | Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner | 388,642 | $9.2307 | $3,587,443 | 4,721,992 (Direct) | View |
| 2023-01-27 Sale | 2023-01-31 4:30 pm | Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner | 50,000 | $9.02 | $451,000 | 5,110,634 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 5:23 pm | Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner | 150,000 | $9.2533 | $1,388,000 | 5,160,634 (Direct) | View |
| 2023-01-20 Sale | 2023-01-24 6:20 pm | Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner | 155,000 | $9.1181 | $1,413,300 | 5,310,634 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:57 pm | Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel | 2,188 | $9.8487 | $21,549 | 112,775 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:55 pm | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 1,106 | $9.8485 | $10,892 | 35,088 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:53 pm | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 2,188 | $9.8487 | $21,549 | 51,903 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-15 Exercise | 2023-09-18 4:44 pm | N/A 2032-01-13 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $0 | 94,360 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-18 4:44 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $2.85 | 94,360 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-11 4:46 pm | N/A 2033-07-10 | Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer | 122,000 | $0 | 122,000 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-05 4:32 pm | N/A 2032-01-13 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $0 | 110,360 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-05 4:32 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 5,000 | $2.85 | 110,360 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:41 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:40 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | MACKEY CATHERINE J Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:40 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:39 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:38 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:37 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Colon Grace Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:36 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:35 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:34 pm | N/A 2033-06-06 | Voyager Therapeutics Inc. | VYGR | Hyman Steven Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 5:15 pm | N/A 2033-05-09 | Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:19 pm | N/A 2033-02-23 | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 44,000 | $0 | 44,000 (Direct) | View |
Ownership | 2023-02-27 5:16 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Onyia Jude Director | 0 | $0 | 2,910 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:57 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer | 102,000 | $0 | 135,553 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:55 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer | 114,000 | $0 | 239,000 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:52 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer | 120,000 | $0 | 171,903 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-22 8:51 pm | N/A 2033-02-17 | Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO | 360,000 | $0 | 462,055 (Direct) | View |
| 2023-02-02 Other | 2023-02-06 4:30 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner | 1,500,000 | $0 | 4,771,556 (Direct) | View |